Heart defect repaired with a fully absorbable device, a "European first" at the Sant'Eugenio Hospital in Rome.
Innovative percutaneous treatment for atrial septal defects. The goal is a minimally invasive approach for anomalies such as patent foramen ovale. Among the advantages is the reduction of long-term complications associated with the presence of a permanent prosthetic material. It repairs the heart defect and then reabsorbs. At Sant'Eugenio Hospital in Rome, "the first cases in Europe" have been performed.
The New Frontier of Sedation: Virtual Reality Instead of Drugs
Drug-free sedation through virtual reality – a new approach.
Right heart remodeling after bicaval TricValve implantation in patients with severe tricuspid regurgitation.
From 16 to 19 May 2023, the specific program of P+F Products + Features GmbH in the forthcoming Euro PCR 2023 will be held at the Palais des Congrès in Paris.
Transcatheter heterotopic valve implantation with the TricValve system: focus on preoperative evaluation and patient selection.
Untreated severe symptomatic tricuspid valve regurgitation is associated with significant morbidity and mortality. When surgical correction is not feasible due to high operative risk, transcatheter tricuspid valve treatment has been suggested as an attractive value option.
Prof Gaspardone on La7 for Noblestitch
Prof. Gaspardone spoke on LA7 to talk about the innovative Noblestitch device
The Resorbable Stent
The coronary stent, invented by Julio Palmaz in 1987, was defined by the prestigious IP Worldwide Magazine as one of the ten inventions of the 20th century that helped change the world.